Literature DB >> 6137372

Renal effects of beta blockade in essential hypertension.

P W de Leeuw, W H Birkenhäger.   

Abstract

In this paper the effects of beta blockade on renal haemodynamics are reviewed. Although renal blood flow often declines during treatment with beta-blocking drugs, in many cases it is possible to demonstrate relative or absolute vasodilation in the kidney. Renal vasoconstriction seems to be a predominant pattern in patients who do not exhibit a hypotensive response. The mechanism of the changes in renal vascular tone is still not fully understood. The renin-angiotensin system behaves only passively and cannot be held responsible. Evidence is presented that changes in local adrenergic activity may determine the response of the kidney to chronic beta blockade.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6137372     DOI: 10.1093/eurheartj/4.suppl_d.13

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  5 in total

1.  Therapeutic benefits and safety of carvedilol in the treatment of renal hypertension. An open, short term study. Carvedilol Renal Hypertension Study Group in Japan.

Authors:  M Kohno; T Takeda; M Ishii; T Saruta; Y Mizuno; M Yoshimura; S Kubo; K Fukiyama; M Fujishima
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  Role of age-related decrease of renal organic cation transporter 2 in the effect of atenolol on renal excretion of metformin in rats.

Authors:  Jiangxia Ren; Yan Zhou; Guoqiang Zhang; Liting Zhou; Jing Zhao; Yuhui Wei; Xin'an Wu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-07-01       Impact factor: 2.441

3.  Effects of amlodipine on renal haemodynamics in mild to moderate hypertensive patients. A randomized controlled study versus placebo.

Authors:  G Licata; R Scaglione; A Ganguzza; G Parrinello; R Costa; G Merlino; S Corrao; P Amato
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Antihypertensive efficacy and effects of nitrendipine on cardiac and renal hemodynamics in mild to moderate hypertensive patients: randomized controlled trial versus hydrochlorothiazide.

Authors:  R Scaglione; A Indovina; G Parrinello; R Lipari; L G Mulè; A Ganguzza; G Capuana; C G Stampino; G Licata
Journal:  Cardiovasc Drugs Ther       Date:  1992-04       Impact factor: 3.727

5.  Efficacy and safety of carvedilol in renal hypertension. A multicenter open trial.

Authors:  T Takeda; M Kohno; M Ishii; S Kubo; T Saruta; Y Mizuno; K Fukiyama; M Fujishima; M Yoshimura
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.